Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...

Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...

Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an ...

A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...

The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, ...

On Friday, Sept. 27, lawmakers reintroduced the Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill ...

Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major ...

Prime Cabinet Secretary Musalia Mudavadi states that the government of Kenya has intensified efforts to tackle the challenge ...

Zoe Davis, a 20-year-old student, continues to battle severe sickle cell pain while hoping for relief from new gene therapies ...

Rochester, N.Y. The classmates of a young woman who passed away from sickle cell disease are giving back in her memory.

Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 ...